HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
about
Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a reviewFactors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use.Factors Influencing Uptake of Rapid HIV and Hepatitis C Screening Among Drug Misusing Adult Emergency Department Patients: Implications for Future HIV/HCV Screening Interventions.HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, CaliforniaCause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City.Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?Progress realized: trends in HIV-1 viral load and CD4 cell count in a tertiary-care center from 1999 through 2011National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional studyTreatment, care and support for people co-infected with HIV and hepatitis C: a scoping review.Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain.Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms.Awareness of hepatitis C infection among women with and at risk for HIV.Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patientsTriple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection.Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populationsBarriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.The role of viral co-infection in HIV-associated non-AIDS-related cancersShort communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients.Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection.Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis.Prevalence and correlates of emotional distress in HIV/HCV coinfection.Human immunodeficiency virus and hepatitis C virus coinfection in Nepal.Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.Joint Modeling of Mixed Plasmodium Species Infections Using a Bivariate Poisson Lognormal Model.Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men.
P2860
Q27010548-6C3428F3-0B91-4508-BBAF-16C24145CB17Q30381373-4D4E6438-05B1-421E-8C1C-13CBBA917A3BQ30667479-F8DCF70A-957D-451D-B21C-0253F6DF7C80Q30837913-D5A17BFB-DB14-40D1-B900-88B34D0EDEF8Q33294712-A40AAAF0-CC39-423B-888C-0F3AA6470EBCQ34077806-38ED64C9-7AA7-4A9F-8792-D125777C883AQ34403692-311B7BF9-08BF-4797-B822-9A19F6EAE2C2Q34599593-519C698E-3810-48DA-9083-A3729ED7FAE8Q34873781-95D2DEB1-0919-412D-A14B-7E7BA95BC8A8Q34954320-3EEA6DD0-F704-4EAD-BACC-19F1907E24D2Q35980035-B0C8804C-56FA-4386-96F3-D31F6540B7D3Q36014872-DFE09836-4638-47E4-9578-4B9D3409C461Q36379622-B939691A-1449-4C50-B6CE-5E605F281778Q36416942-D7D6BFBF-ABDE-426C-96D6-1D2E35446673Q36501932-E071B0BD-B6F9-484C-B498-5C796B35B418Q36612848-EF6814B7-878B-4494-A39B-F3B195B8968AQ36654120-FC75921A-482B-47DA-9CE1-889DCF9C594CQ36843554-B7ADAC33-08E8-4429-A113-8750B1E0D77EQ36906779-73710DAC-4E89-4CF5-9059-955107094ED4Q36949481-B36D33DD-334B-4E5C-8057-083925D3F6E9Q36960884-1F0E4E72-5EE1-49BC-A959-3719FFB79FCDQ37111444-27FD6B5E-7602-4907-9CC1-611CC80E27F8Q37235521-DEA4ABA0-B4C8-4E59-B2C8-D9A34C045EADQ37256940-2C61B834-6B96-4CD8-83BA-9706694A5BAFQ37415707-8CDC0BF5-F0BB-4E13-BF9B-B7300ACC0C36Q38052034-FD9134D3-BD69-4AD7-813B-06427FBE03C8Q38180719-B606D984-C4B1-41C9-8EE6-4F564374A54FQ39093985-6526AA6A-B570-4F7C-95BF-DDF79F40E64FQ42225536-CEBC0FAF-FFE3-4985-BD1F-18C970708679Q42265849-747A1819-B93D-48DA-8AB3-0A9460053318Q43033701-A27E97E8-1CD9-43EA-86DD-E161CF4D3A4AQ46184319-796EAC73-29FE-4385-950F-5BEC1FC03E52Q46955676-50C0B3FB-24C3-4041-B3D5-6E68BCEC0B37
P2860
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@en
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@nl
type
label
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@en
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@nl
prefLabel
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@en
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@nl
P2093
P1433
P1476
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
@en
P2093
Derek Boothroyd
Lawrence R Deyton
Lisa I Backus
P356
10.1097/01.AIDS.0000192065.09281.01
P407
P478
19 Suppl 3
P577
2005-10-01T00:00:00Z